Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)

by Sherwood, James L., Corcoran, Claire, Brown, Helen, Sharpe, Alan D., Musilova, Milena, Kohlmann, Alexander
Published 2016

miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer

by Corcoran, Claire, Rani, Sweta, Breslin, Susan, Gogarty, Martina, Ghobrial, Irene M, Crown, John, O’Driscoll, Lorraine
Published 2014

Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

by Corcoran, Claire, Rani, Sweta, O’Brien, Keith, O’Neill, Amanda, Prencipe, Maria, Sheikh, Rizwan, Webb, Glenn, McDermott, Ray, Watson, William, Crown, John, O’Driscoll, Lorraine
Published 2012

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

by O'Neill, Amanda J, Prencipe, Maria, Dowling, Catherine, Fan, Yue, Mulrane, Laoighse, Gallagher, William M, O'Connor, Darran, O'Connor, Robert, Devery, Aoife, Corcoran, Claire, Rani, Sweta, O'Driscoll, Lorraine, Fitzpatrick, John M, Watson, R William G
Published 2011

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

by O'Brien, Keith, Lowry, Michelle C., Corcoran, Claire, Martinez, Vanesa G., Daly, Melissa, Rani, Sweta, Gallagher, William M., Radomski, Marek W., MacLeod, Roderick A.F., O'Driscoll, Lorraine
Published 2015